The society of Environmental Toxicology and Chemistry (SETAC) celebrates its 32nd European Annual Meeting. This year will take place on the 15-19th May in Copenhagen, Denmark and online. The event is getting closer and the PREMIER partners are preparing to present some of the results produced during the project.

A variety of PREMIER partners from both public and private organisation will attend the upcoming SETAC Europe conference. Among the public participants, there will be partners from the Radboud University Nijmegen (RU), ECT Oekotoxikologie GmbH (ECT) and the Swiss Federal Institute of Aquatic Science and Technology (EAWAG). PREMIER will also have representation from the industry side with partners from AstraZeneca (AZ) and Bayer attending the meeting.

Partners will deliver conference presentations on topics such as minimising fish testing for legacy pharmaceuticals, kinetic models for fish and API prioritisation. Additionally, early career researchers from PREMIER will also have the chance to present their work via poster presentations to showcase their work on read-across approaches, and transformation products of pharmaceuticals.

Additionally, some of our consortium members will also chair some sessions on Pharmaceuticals in the environment or Environmental policy.

Don´t miss out the PREMIER partners presentations! Take a look below for more information:

Presentations

PresentationAuthorsDate & Session
Minimising experimental testing on fish for legacy pharmaceuticalsAnja Coors (ECT), Ross Brown, Charles Tyler (Exeter), Sam Maynard, Stewart Owen (AZ), Alison Perkins (Eli Lilly)Tue 17 May 2022 (10:40 – 14:45 CET) – Session: Pharmaceuticals in the environment – New insights, regulatory needs and knowledge gaps
A generalised physiologically based kinetic model for fish for environmental risk assessment of pharmaceuticalsJiaqi Wang (RU), Jan Hendriks (RU), Stewart Owen (AZ), Ad Ragas (RU)Tue 17 May 2022 (8:35 – 9:55 CET) – Session: Toxicokinetics and toxicodynamics in chemical risk assessment: data collection and model development
Recent Developments and Applications of the Exposure to Pharmaceuticals in the Environment, ePiE, ModelFrancesco Bregoli (RU), Tom Austin (RU), Ad Ragas (RU)Tuesday, 17 May 2022 (10:40 – 14:45 CET) – Session: Pharmaceuticals in the environment – New insights, regulatory needs and knowledge gaps

Posters

TopicAuthorsDate & Session
Potential of read-across approaches for the biotransformation of organic contaminants between activated sludge and standard OCED 307 – 308 testsClaudia Coll, Kathrin Fenner (eawag)Wednesday 18th May 2022 – Session: Persistent, Mobile and Toxic (PMT/vPvM) substances: New Perspectives and Developments in their Assessment, Management and Regulation
Transformation products of pharmaceuticals – comparison of predictions with observations in environmental simulation studies Leo Trostel, Claudia Coll, Jasmin Hafner, Kathrin Fenner (eawag)Wednesday 18th May 2022 – Session: Persistent, Mobile and Toxic (PMT/vPvM) substances: New Perspectives and Developments in their Assessment, Management and Regulation
Expanding the biodegradation database in enviPath to predict transformation products half-lives and in soil and sediment Jasmin Hafner, Moritz Salz, Emanuel Schmid, Kunyang Zhang, Kathrin Fenner (eawag)Wednesday 18th May 2022 – Session: Persistent, Mobile and Toxic (PMT/vPvM) substances: New Perspectives and Developments in their Assessment, Management and Regulation
Prioritization of active pharmaceutical ingredients based on predicted environmental risk Cristiana Cannata (RU), Ad Ragas (RU), Thomas Backhaus (UGOT), Anna Lombardo (MN), Rhys Whomsley (EMA), Stewart Owen (AZ) Tuesday 17th May 2022 – Session: Pharmaceuticals in the environment. New insights, regulatory needs and knowledge gaps